https://www.surveymonkey.com/r/McGuireNomination26
2026 SABCS William L. McGuire Award Nominations Survey
Take this survey powered by surveymonkey.com. Create your own surveys for free.
award nominationssabcswilliammcguiresurvey
https://sabcs.org/
San Antonio Breast Cancer Symposium® | SABCS 2026
Jul 14, 2026 - The San Antonio Breast Cancer Symposium® (SABCS) is the world’s largest breast cancer research meeting, where leading scientists and clinicians share the...
san antoniobreast cancersabcs
https://www.bestofsabcs.com/
Best of SABCS
best ofsabcs
https://www.sabcsmeetingnews.org/
Home - SABCS Meeting News
Jan 29, 2026 - Latest news from SABCS 2025 JANUARY 29, 2026 SABCS® 2025 Takeaways Explore some of the notable discussions and potentially practice-changing data that were...
sabcsmeetingnews
https://breastcancer.apac.knowledgehub.wiley.com/kol-commentaries/sabcs-symposium-2023-highlights/
SABCS Symposium 2023 Highlights - Breast Cancer Resources for Healthcare Professionals | Wiley...
breast cancer resourcesfor healthcare professionalssabcssymposiumhighlights
https://breastcancer.apac.knowledgehub.wiley.com/videos/independent-highlights-sabcs-2025/
Independent highlights of San Antonio Breast Cancer Symposium (SABCS) 2025 - Breast Cancer...
Feb 19, 2026 - Videos Video highlights from the San Antonio Breast Cancer Symposium (SABCS) 2025
san antoniobreast cancerindependenthighlightssymposium
https://markets.businessinsider.com/news/stocks/briacell-presents-phase-2-phase-3-data-on-bria-imt-at-sabcs-2025-1035634446
BriaCell presents Phase 2, Phase 3 data on Bria-IMT at SABCS 2025 | Markets Insider
BriaCell (BCTX) Therapeutics presents positive Phase 2 survival, and Phase 3 biomarker data across three clinical posters at the 2025 San Antoni...
https://markets.businessinsider.com/news/stocks/briacell-to-present-phase-2-survival-phase-3-data-at-sabcs-2025-1035611383
BriaCell to present Phase 2 survival, Phase 3 data at SABCS 2025 | Markets Insider
BriaCell (BCTX) Therapeutics will be presenting positive Phase 2 survival, and Phase 3 biomarker data across three clinical posters at the 2025 ...
https://www.businesswire.com/news/home/20251208979141/en/SABCS-2025-REVEAL-GENOMICS-Presents-Major-Advance-in-Predicting-Brain-Metastasis-in-HER2-Breast-Cancer
SABCS 2025: REVEAL GENOMICS Presents Major Advance in Predicting Brain Metastasis in HER2+ Breast...
REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker innovation, announced today the pres...